Development of an ASRS-Based Photoguide for a Clinical Trial of TRTP-101 in Adults With Atrophic Scars
CIC101-02-PG aims to develop an ASRS-based photoguide for patients with atrophic acne scars.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: HyeJung Park
- Phone Number: +82-70-4469-9115
- Email: hjpark@cellincells.com
Study Locations
-
-
-
Seoul, South Korea
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Individuals with Atrophic scars
Description
Inclusion Criteria:
- Male or Female aged greater than 19 years
- Participants with any grade according to the 5-point Acne Scar Rating Scale (ASRS)
- Participants who voluntarily provide written informed consent to participate in this clinical trial
Exclusion Criteria:
- Participants with an infectious condition or any dermatologic condition other than atrophic scars on the face
- Participants with a any current serious acute, chronic, or progressive disease
- Participants who are considered unsuitable for participation in the clinical trial for any other reason, as determined by the investigator
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Cohort 1: ASRS grade 0
Participants classified as ASRS Grade 0 |
|
Cohort 2: ASRS grade 1
Participants classified as ASRS Grade 1 |
|
Cohort 3: ASRS grade 2
Participants classified as ASRS Grade 2 |
|
Cohort 4: ASRS grade 3
Participants classified as ASRS Grade 3 |
|
Cohort 5: ASRS grade 4
Participants classified as ASRS Grade 4 |
|
5 ASRS grade Cohorts
Participants are classified into five cohorts according to ASRS Grades 0-4. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inter-rater Reliability of the Acne Scar Rating Scale (ASRS)
Time Frame: Within 4 weeks after completion of photograph collection
|
Inter-rater reliability of ASRS grading is assessed among three independent evaluators using standardised photographs of atrophic acne scars. Agreement among evaluators will be quantified using Fleiss' weighted kappa statistic. |
Within 4 weeks after completion of photograph collection
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra-rater Reliability of the Acne Scar Rating Scale (ASRS)
Time Frame: Within 4 weeks after completion of photograph collection
|
Intra-rater reliability of ASRS grading is assessed for each of the three independent evaluators using 13 repeated photographs. Agreement between repeated assessments will be quantified using Cohen's weighted kappa statistic. |
Within 4 weeks after completion of photograph collection
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- CIC101-02-PG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.